NL-OMON43017已完成不适用
Free circulating tumour DNA in patients with peritoneal metastases of colorectal origin and HIPEC therapy; LIBEC trial - a feasibility study - LIBEC trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Orally and written informed consent
- •- Age 18 years and older
- •- Elective cytoreductive surgery followed by HIPEC
- •- Peritoneal metastases only
- •- Regular preoperative work-up
排除标准
- •- Patients who are legally or mentally incapable or unable to give informed consent
- •- Patients younger than 18 years
- •- Presence of liver metastases on CT-scan
- •- Presence of pulmonary metastases on CT-scan
- •- Anxiety for vena puncture
研究者
相似试验
招募中
不适用
Circulating Tumour DNA in Stage 1 to 4 Ovarian CancerOvarian cancerACTRN12617001119381Walter and Eliza Hall Institute of Medical Research100
尚未招募
不适用
Circulating Tumour DNA as a Marker of Complete Pathological Response and Long Term Outcome for Locally Advanced Rectal Cancer Treated with Pre-operative ChemoradiotherapyACTRN12612000327886udwig Institute for Cancer Research320
招募中
不适用
Multicenter Study of Circulating Tumor DNA in Patients with Pancreatic Cancer Using a Personalized PanelResectable and unresectable pancreatic cancerJPRN-UMIN000043561ational Cancer Center Hospital East150
招募中
不适用
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patientsmetastatic prostate cancerNL-OMON24467Erasmus Medical Center95
招募中
不适用
Circulating tumor DNA for minimal residual disease in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant: a multi-center prospective study.Acute Myeloid Leukemia, Myelodysplastic SyndromesJPRN-UMIN000033003Kanto Study Group for Cell Therapy70